bilcare Research
Home  |  Contact Us
 
Increase text size Restore default text size Decrease text size
About Us
About Bilcare Vision & Values Leadership Team Awards & Recognition Innovation Culture News Careers
 
 

Press Releases

Press Releases   |  Bilcare in News   |   Media Kit   |  Downloads  |  Media Contact


August 31, 2009

Bilcare Board proposes the issue of Global Depository Receipts (GDR) worth USD 35 million

Click here to download PDF


Bilcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 29, 2009, has approved and proposed the Issue of Global Depository Receipts (GDR)/ Equity Shares by the Company, not exceeding USD 35 million subject to required approvals, including approval of Members of the Company.

About Bilcare :

Bilcare aims at transforming healthcare outcome through its international integrated services (to the global pharmaceutical industry) through its key business activities namely: Pharma Packaging Research, Global Clinical Services, and Non-Clonable Technologies in security & product authentication and medication compliance. Bilcare operates state-of-the-art Manufacturing and Research facilities in India, Singapore, USA & UK and has regional offices in Brazil, Germany, China & Australia. Bilcare partners with the global pharmaceutical sector by providing value solutions to address their key concerns viz. counterfeit, compliance, cost communication and convenience.
(Visit us at www.bilcare.com)

Press Contact:

Jaydip Chowdhury
Head Corporate Communications
Phone: 020 30257787
Email: Jaydip.Chowdhury@Bilcare.com

 
 

Corporate Fact Sheet

 
 
 
© 2009-2010, Bilcare Limited. All Rights Reserved. Disclaimer Site Map Privacy Policy Content + Design Riteverses